Literature DB >> 30902794

CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages.

Jie Ji1, Peiru Wang1, Qian Zhou1, Lude Zhu1, Haiyan Zhang1, Yunfeng Zhang1, Zhe Zheng1, Anil Kumar Bhatta1, Goulong Zhang2, Xiuli Wang3.   

Abstract

BACKGROUND: Antitumor immunity induced by photodynamic therapy (PDT) is believed to depend on the degree of local and systemic inflammation. The recruitment of leukocytes, in particular by the chemokine CCL8, to the sites of tissue damage has been strongly associated with the initiation of inflammatory reactions.
OBJECTIVE: To evaluate whether and how CCL8 enhances the immune response against tumors in 5-aminolevulinic acid (ALA)-mediated PDT.
METHODS: In this study, we investigated the effect of ALA-PDT-induced CCL8 expression on the recruitment and polarization of macrophages using immunohistochemistry, western blot and Transwell cell migration assay. We evaluated CCL8 expression following ALA-PDT in vitro and in vivo by using RT-PCR, western blot, and ELISA in clinical cutaneous squamous cell carcinoma (cSCC) samples, a mouse model of cSCC, tumor cells, and macrophages. The effect of the combination of ALA-PDT with CCL8 treatment on anti-tumor immunity was tested in the mouse model.
RESULTS: We found that ALA-PDT enhanced CCL8 expression, increased the number of macrophages in tumor, and stimulated their M1 pro-inflammatory phenotype characterized by high expression levels of CD16 and CD80, low expression level of CD163, and absence of CD206 expression. Furthermore, CCL8 enhanced the effect of ALA-PDT on cSCC in mice, such a combination of CCL8 and ALA-PDT had a stronger positive effect in the treatment of mouse cSCC than PDT alone and suppressed tumor volume regrowth.
CONCLUSION: ALA-PDT induces CCL8 expression and recruits M1 macrophages, thus suppressing tumor growth.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  5-aminolevulinic acid-mediated photodynamic therapy; CCL8/MCP-2; Cutaneous squamous cell carcinoma; Immune effects; Photodynamic therapy; Tumor-associated macrophage

Mesh:

Substances:

Year:  2019        PMID: 30902794     DOI: 10.1016/j.pdpdt.2019.03.014

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  3 in total

1.  Topical therapy for regression and melanoma prevention of congenital giant nevi.

Authors:  Yeon Sook Choi; Tal H Erlich; Max von Franque; Inbal Rachmin; Jessica L Flesher; Erik B Schiferle; Yi Zhang; Marcello Pereira da Silva; Alva Jiang; Allison S Dobry; Mack Su; Sharon Germana; Sebastian Lacher; Orly Freund; Ezra Feder; Jose L Cortez; Suyeon Ryu; Tamar Babila Propp; Yedidyah Leo Samuels; Labib R Zakka; Marjan Azin; Christin E Burd; Norman E Sharpless; X Shirley Liu; Clifford Meyer; William Gerald Austen; Branko Bojovic; Curtis L Cetrulo; Martin C Mihm; Dave S Hoon; Shadmehr Demehri; Elena B Hawryluk; David E Fisher
Journal:  Cell       Date:  2022-05-12       Impact factor: 66.850

Review 2.  Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical Recommendations.

Authors:  Irati Beltrán Hernández; Yingxin Yu; Ferry Ossendorp; Mladen Korbelik; Sabrina Oliveira
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

Review 3.  Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.

Authors:  Shahang Luo; Guanghui Yang; Peng Ye; Nengqi Cao; Xiaoxia Chi; Wen-Hao Yang; Xiuwen Yan
Journal:  Biomolecules       Date:  2022-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.